Trial Profile
An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Oxaliplatin and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Solid tumours
- Focus Adverse reactions
- 24 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.